Wende Presents at WashU Genetics Seminar

Dr. Adam Wende delivered a seminar on cutting-edge epigenetic research in the setting of heart disease at Washington University in St. Louis (WashU). Dr. Wende’s presentation, titled “Metabolic signaling in transcriptional control of heart failure,” took place on September 05, 2024. Wende had previously received his PhD from WashU.

This seminar highlighted recent breakthroughs in Wende Lab’s research on how poor glycemic control, even when corrected, continues to influence disease progression. His seminar presented compelling evidence for glucose-mediated regulation of transcriptional changes linked to pathological cardiac remodeling.

Congratulations to Dr. Wende for this prestigious opportunity!

Wende appointed to new UCEM T32 leadership role

08/17/2023

Adam Wende, Ph.D., UCEM Scientist and co-leader of UCEM Pre-Clinical Research Team has been appointed as the Associate Director of the UCEM T32 Interdisciplinary Training in Pathobiology and Rehabilitation Medicine Program.
The goal of the training program is to develop burgeoning pre- and post-doctoral candidates into future leaders in translational rehabilitation research—scientists who are equipped to test and disseminate novel rehabilitative strategies that will alleviate impairment and compromised life quality in the face of chronic disease management.